BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9342133)

  • 1. Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT.
    McCall WV; Zvara D; Brooker R; Arias L
    Convuls Ther; 1997 Sep; 13(3):175-80. PubMed ID: 9342133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy.
    Zvara DA; Brooker RF; McCall WV; Foreman AS; Hewitt C; Murphy BA; Royster RL
    Convuls Ther; 1997 Sep; 13(3):165-74. PubMed ID: 9342132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ictal EEG regularity declines during a course of RUL ECT.
    McCall WV; Colenda CC; Farah BA
    Convuls Ther; 1996 Dec; 12(4):213-6. PubMed ID: 9034695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
    Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N
    Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics.
    Weinger MB; Partridge BL; Hauger R; Mirow A
    Anesth Analg; 1991 Nov; 73(5):556-62. PubMed ID: 1952135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-blockers and electroconvulsive therapy: a review].
    van den Broek WW; Groenland TH; Mulder PG; Kusuma A; Birkenhäger TK; Pluijms EM; Bruijn JA
    Tijdschr Psychiatr; 2008; 50(4):205-15. PubMed ID: 18398800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study.
    van den Broek WW; Leentjens AF; Mulder PG; Kusuma A; Bruijn JA
    Br J Anaesth; 1999 Aug; 83(2):271-4. PubMed ID: 10618942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy.
    Azuma H; Fujita A; Sato K; Arahata K; Otsuki K; Hori M; Mochida Y; Uchida M; Yamada T; Akechi T; Furukawa TA
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):168-73. PubMed ID: 17362434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of esmolol and labetalol to attenuate haemodynamic responses after electroconvulsive therapy.
    Shrestha S; Shrestha BR; Thapa C; Pradhan SN; Thapa R; Adhikari S
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):318-23. PubMed ID: 18604047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemodynamic effects of dexmedetomidine and esmolol in electroconvulsive therapy: a retrospective comparison.
    Aydogan MS; Yücel A; Begec Z; Colak YZ; Durmus M
    J ECT; 2013 Dec; 29(4):308-11. PubMed ID: 23774056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy.
    Kovac AL; Goto H; Arakawa K; Pardo MP
    Can J Anaesth; 1990 Jan; 37(1):58-62. PubMed ID: 1967227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects.
    Perera TD; Luber B; Nobler MS; Prudic J; Anderson C; Sackeim HA
    Neuropsychopharmacology; 2004 Apr; 29(4):813-25. PubMed ID: 14735129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold.
    Coffey CE; Lucke J; Weiner RD; Krystal AD; Aque M
    Biol Psychiatry; 1995 May; 37(10):713-20. PubMed ID: 7640326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of ECT by intravenous administration of theophylline.
    Leentjens AF; van den Broek WW; Kusuma A; Bruijn JA
    Convuls Ther; 1996 Dec; 12(4):232-7. PubMed ID: 9034698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy.
    Sawayama E; Takahashi M; Inoue A; Nakajima K; Kano A; Sawayama T; Okutomi T; Miyaoka H
    J ECT; 2008 Sep; 24(3):195-8. PubMed ID: 18772703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs.
    Geretsegger C; Rochowanski E; Kartnig C; Unterrainer AF
    J ECT; 1998 Mar; 14(1):28-35. PubMed ID: 9661091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of age and sex on electroconvulsive therapy using remifentanil as the sole anesthetic agent.
    Hossain A; Sullivan P
    J ECT; 2008 Sep; 24(3):232-5. PubMed ID: 18562948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEG effects of ECT: implications for rTMS.
    Krystal AD; West M; Prado R; Greenside H; Zoldi S; Weiner RD
    Depress Anxiety; 2000; 12(3):157-65. PubMed ID: 11126190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. Effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and cortisol.
    Weinger MB; Partridge BL; Hauger R; Mirow A; Brown M
    Anesth Analg; 1991 Nov; 73(5):563-9. PubMed ID: 1659253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.